Neurocrine Bioscience buy Royal Bank of Canada
Start price
02.06.25
/
50%
€108.85
Target price
02.06.26
€127.53
Performance (%)
1.01%
Price
10.04.26
€109.95
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 1.01%. This prediction currently runs until 02.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.637% | -3.637% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $145.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.60
12.02.26
12.02.26
€149.00
12.02.27
12.02.27
4.12%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€137.35
08.12.25
08.12.25
€154.48
08.12.26
08.12.26
-19.95%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€137.36
29.10.26
29.10.26
-6.70%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.05
05.09.25
05.09.25
€127.74
05.09.26
05.09.26
-10.65%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€125.97
31.07.26
31.07.26
-2.22%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€128.38
06.05.26
06.05.26
3.82%
10.04.26
10.04.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€83.38
14.04.25
14.04.25
€120.31
14.04.26
14.04.26
31.87%
10.04.26
10.04.26